Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of General Psychiatry
Published in: Annals of General Psychiatry 1/2019

Open Access 01-12-2019 | Affective Disorder | Primary research

Factor structure and diagnostic efficiency of the Myanmar version BDI-II among substance users

Authors: Khine Lae Win, Norito Kawakami, Gyaw Htet Doe

Published in: Annals of General Psychiatry | Issue 1/2019

Login to get access

Abstract

Background

The Beck Depression Inventory II (BDI-II) has been accepted as one of the most commonly used self-report measures for depression. However, there is no study examining the psychometric properties of the BDI-II among substance users in low- and middle-income countries such as Myanmar. Therefore, this study aimed to evaluate the suitability of using this instrument in substance users and to examine the reliability and diagnostic efficiency to be compared with the International Classification of Diseases (ICD-10) among substance users in Northern Shan State of Myanmar.

Methods

A respondent-driven sampling (RDS) method was applied for recruiting the participants in this study, and total 230 substance users were recruited. On the other hand, 50 participants who visited the drop-in center (DIC) were screened for depressive symptoms using ICD-10 during the days when one consultant psychiatrist doctor was presented. These participants were interviewed face-to-face by the consultant psychiatrist using a semi-structured questionnaire including the Myanmar version of the BDI-II (mBDI-II).

Results

The mBDI-II showed moderate accuracy with an area under the curve of 0.68. The optimal cutoff score was 10 with the highest Youden index (0.48), and it had high sensitivity and specificity (0.78 and 0.70). The Cronbach’s alpha coefficients for clinically depressed and non-clinically depressed substance users were 0.91 and 0.93, respectively. Confirmatory factor analysis of the mBDI-II indicated that a three-factor solution (cognitive, affective, and somatic) was the best fit for substance users.

Conclusions

The mBDI-II has sound psychometric properties among substance users with moderate accuracy and range of possible cutoff scores together with sensitivity and specificity.
Literature
1.
Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807–16.CrossRef
2.
Lai HMX, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug Alcohol Depend. 2015;154(2):1–13.CrossRef
3.
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264(19):2511–8.CrossRef
4.
Currie SR, Patten SB, Williams JV, Wang J, Beck CA, El-Guebaly N, et al. Comorbidity of major depression with substance use disorders. Can J Psychiatry. 2005;50(10):660–6.CrossRef
5.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). Philadelphia: American Psychiatric; 2013.CrossRef
6.
Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry. 2006;163(4):689–96.CrossRef
7.
Beck AT, Steer RA, Brown GK. Beck depression inventory-II. San Antonio. 1996;78(2):490–8.
8.
McDowell I. Measuring health: a guide to rating scales and questionnaires. Oxford: Oxford University Press; 2006.CrossRef
9.
Gomes-Oliveira MH, Gorenstein C, Lotufo Neto F, Andrade LH, Wang YP. Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample. Rev Bras Psiquiatr. 2012;34(4):389–94.CrossRef
10.
Hobkirk AL, Starosta AJ, De Leo JA, Marra CM, Heaton RK, Earleywine M, et al. Psychometric validation of the BDI-II among HIV-positive CHARTER study participants. Psychol Assess. 2015;27(2):457–66.CrossRef
11.
Joe S, Woolley ME, Brown GK, Ghahramanlou-Holloway M, Beck AT. Psychometric properties of the Beck Depression Inventory-II in low-income, African American suicide attempters. J Pers Assess. 2008;90(5):521–3.CrossRef
12.
Kim MH, Mazenga AC, Devandra A, Ahmed S, Kazembe PN, Yu X, et al. Prevalence of depression and validation of the Beck Depression Inventory-II and the Children’s Depression Inventory-Short amongst HIV-positive adolescents in Malawi. J Int AIDS Soc. 2014;17(1):18965.CrossRef
13.
Arnarson O, Olason D, Smari J, Sigurdsson JF. The Beck Depression Inventory Second Edition (BDI-II): psychometric properties in Icelandic student and patient populations. Nordic J Psychiatry. 2008;62(5):360–5.CrossRef
14.
Basker M, Moses PD, Russell S, Russell PSS. The psychometric properties of Beck Depression Inventory for adolescent depression in a primary-care paediatric setting in India. Child Adolesc Psychiatr Mental Health. 2007;1(1):8.CrossRef
15.
Russell PS, Basker M, Russell S, Moses PD, Nair MKC, Minju KA. Comparison of a self-rated and a clinician-rated measure for identifying depression among adolescents in a primary-care setting. Indian J Pediatr. 2012;79(1):45–51.CrossRef
16.
Mahmud WMRW, Awang A, Herman I, Mohamed MN. Analysis of the psychometric properties of the Malay version of Beck Depression Inventory II (BDI-II) among postpartum women in Kedah, North West of Peninsular Malaysia. MJMS. 2004;11(2):19.
17.
Dum M, Pickren J, Sobell LC, Sobell MB. Comparing the BDI-II and the PHQ-9 with outpatient substance abusers. Addict Behav. 2008;33(2):381–7.CrossRef
18.
Hepner KA, Hunter SB, Edelen MO, Zhou AJ, Watkins K. A comparison of two depressive symptomatology measures in residential substance abuse treatment clients. J Subst Abuse Treat. 2009;37(3):318–25.CrossRef
19.
Johnson ME, Neal DB, Brems C, Fisher DG. Depression as measured by the Beck Depression Inventory-II among injecting drug users. Assessment. 2006;13(2):168–77.CrossRef
20.
Seignourel PJ, Green C, Schmitz JM. Factor structure and diagnostic efficiency of the BDI-II in treatment-seeking substance users. Drug Alcohol Depend. 2008;93(3):271–8.CrossRef
21.
Buckley TC, Parker JD, Heggie J. A psychometric evaluation of the BDI-II in treatment-seeking substance abusers. J Subst Abuse Treat. 2001;20(3):197–204.CrossRef
22.
McCreesh N, Frost SD, Seeley J, Katongole J, Tarsh MN, Ndunguse R, et al. Evaluation of respondent-driven sampling. Epidemiology. 2012;23(1):138–47.CrossRef
23.
Beck AT, Steer RA, Brown GK. BDI-II, Beck depression inventory: manual. San Antonio: Psychological Corp.; 1996.
24.
Isaac M, Janca A, Sartorius N, Organization WH. ICD-10 symptom glossary for mental disorders: a glossary of symptoms used in the definition of criteria for the classification of mental and behavioural disorders in the 10th revision of the International Classification of Diseases (ICD-10). Geneva: World Health Organization; 1994.
25.
26.
Wang Y, Gorenstein C. Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Revista Brasileira De Psiquiatria. 2013;35(4):416–31.CrossRef
27.
Siddiqui S, Ali Shah SA. Siddiqui-shah depression scale (SSDS): development and validation. Psychol Dev Soc. 1997;9(2):245–62.
28.
Kim G, Chiriboga DA, Jang Y. Cultural equivalence in depressive symptoms in older white, black, and Mexican–American adults. J Am Geriatr Soc. 2009;57(5):790–6.CrossRef
29.
Lerdal A, Kottorp A, Gay CL, Grov EK, Lee KA. Rasch analysis of the Beck Depression Inventory-II in stroke survivors: a cross-sectional study. J Affect Disord. 2014;158:48–52.CrossRef
30.
Wang YP, Gorenstein C. Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression Inventory-II. Clinics (Sao Paulo). 2013;68(9):1274–87.CrossRef
Metadata
Title
Factor structure and diagnostic efficiency of the Myanmar version BDI-II among substance users
Authors
Khine Lae Win
Norito Kawakami
Gyaw Htet Doe
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue 1/2019
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/s12991-019-0236-4

Other articles of this Issue 1/2019

Annals of General Psychiatry 1/2019 Go to the issue

Case report

Delusional parasitosis in dementia with Lewy bodies: a case report

Primary research

The relationship between smartphone addiction and symptoms of depression, anxiety, and attention-deficit/hyperactivity in South Korean adolescents

Primary research

Burden among caregivers of people with mental illness at Jimma University Medical Center, Southwest Ethiopia: a cross-sectional study

Primary research

Positive psychological well-being predicts lower severe pain in the general population: a 2-year follow-up study of the SwePain cohort

Primary research

Suicide prevention by emergency nurses: perceived self-efficacy in assessment, management and referral at Kenyatta National Hospital in Kenya

Primary research

Socio-demographic and substance-related factors associated with mental distress among Wollo university students: institution-based cross-sectional study